تقرير
أعرض في EDS

Testosterone Replacement Therapy and the Risk of Hypoglycemia.

التفاصيل البيبلوغرافية
العنوان: Testosterone Replacement Therapy and the Risk of Hypoglycemia.
المؤلفون: Yamaguchi AV; Clinical Medicine Department, Metabolism and Nuclear Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Costanzo PR; Department of Endocrinology, Metabolism and Nuclear Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Peuchot VA; Clinical Medicine Department, Metabolism and Nuclear Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Knoblovits P; Department of Endocrinology, Metabolism and Nuclear Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
المصدر: Case reports in endocrinology [Case Rep Endocrinol] 2019 Nov 17; Vol. 2019, pp. 9616125. Date of Electronic Publication: 2019 Nov 17 (Print Publication: 2019).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 101576457 Publication Model: eCollection Cited Medium: Print ISSN: 2090-6501 (Print) Linking ISSN: 2090651X NLM ISO Abbreviation: Case Rep Endocrinol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Hindawi Pub. Corp.
مستخلص: We report the case of a 45-year-old man with a history of Klinefelter syndrome undergoing testosterone replacement therapy, and with type 2 diabetes treated with metformin with poor metabolic control. When vildagliptin was added to his treatment, he presented hypoglycemia after the testosterone injection. We highlight this not widely reported drug interaction between hypoglycemic agents and testosterone.
Competing Interests: The authors declare that they have no conflicts of interest.
(Copyright © 2019 Analía Verónica Yamaguchi et al.)
References: J Am Geriatr Soc. 1988 Dec;36(12):1092-8. (PMID: 3192887)
J Androl. 2010 May-Jun;31(3):263-70. (PMID: 19834133)
Curr Diab Rep. 2019 Jul 31;19(9):71. (PMID: 31367971)
Diabetes Care. 2019 Jun;42(6):1104-1111. (PMID: 30862651)
World Health Organ Tech Rep Ser. 1985;727:1-113. (PMID: 3934850)
N Engl J Med. 2005 May 26;352(21):2211-21. (PMID: 15917386)
Horm Mol Biol Clin Investig. 2016 May 1;26(2):129-34. (PMID: 27071157)
Lancet. 2007 Jul 14;370(9582):185-191. (PMID: 17630042)
J Clin Endocrinol Metab. 2005 May;90(5):2636-41. (PMID: 15713702)
Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):787-812. (PMID: 24746233)
Endocrinol Diabetes Metab Case Rep. 2017 Sep 04;2017:null. (PMID: 28924480)
Diabetes Care. 2007 Apr;30(4):890-5. (PMID: 17277036)
Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93. (PMID: 16117815)
SAGE Open Med Case Rep. 2019 Jan 16;7:2050313X18823454. (PMID: 30719309)
Eur J Endocrinol. 2006 Jun;154(6):899-906. (PMID: 16728551)
Am J Physiol Endocrinol Metab. 2008 May;294(5):E961-8. (PMID: 18349113)
Andrology. 2014 Jan;2(1):117-24. (PMID: 24282162)
Chin Med J (Engl). 2009 Dec 5;122(23):2846-50. (PMID: 20092788)
Am J Physiol Endocrinol Metab. 2012 Mar 15;302(6):E724-30. (PMID: 22252939)
Sex Med Rev. 2019 Jul;7(3):476-490. (PMID: 30803918)
N Engl J Med. 1996 Feb 29;334(9):574-9. (PMID: 8569826)
J Clin Endocrinol Metab. 2004 Aug;89(8):3830-4. (PMID: 15292313)
Aging Male. 2019 Feb 20;:1-12. (PMID: 30782054)
J Cardiovasc Pharmacol Ther. 2017 Sep;22(5):414-433. (PMID: 28421834)
Metabolism. 2018 Sep;86:61-68. (PMID: 29656047)
Crit Rev Oncol Hematol. 2003 Nov;48(2):133-43. (PMID: 14607376)
تواريخ الأحداث: Date Created: 20191213 Latest Revision: 20201001
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC6885825
DOI: 10.1155/2019/9616125
PMID: 31827946
قاعدة البيانات: MEDLINE
الوصف
تدمد:2090-6501
DOI:10.1155/2019/9616125